ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

Harold Freeman To Direct NCI Center To Reduce Cancer Health Disparities.

September 15, 2000

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994